期刊文献+

白花丹醌对人肝癌SK-hep-1细胞增殖及侵袭的影响 被引量:7

The effects of plumbagin on proliferation and metastasis in human liver cancer SK-hep-1 cells
暂未订购
导出
摘要 背景与目的:白花丹醌是中药白花丹的主要活性成分,对多种肿瘤细胞具有杀伤作用。本研究旨在观察白花丹醌对人肝癌SK-hep-1细胞增殖及侵袭的影响,并初步探讨其作用机制。方法:在体外应用MTS法、软琼脂克隆形成实验、流式细胞术及Transwell小室观察白花丹醌对细胞增殖及侵袭的影响;并通过RTPCR检测白花丹醌对p21、MMP-2及MMP-9的mRNA表达影响。结果:白花丹醌能够明显抑制肝癌SK-hep-1细胞的增殖和克隆形成,且具有剂量依赖性,其半数抑制率为22.04μmol/L。细胞周期分析显示,白花丹醌处理后S期细胞数减少,G0/G1期细胞增多;并且白花丹醌能够抑制SK-hep-1细胞的黏附和侵袭转移。RT-PCR结果显示白花丹醌能够促进p21表达,而抑制MMP-2及MMP-9的表达。结论:白花丹醌可能是通过上调p21及下调MMP-2/MMP-9的表达水平,抑制人肝癌SK-Hep-1细胞增殖和侵袭。 Background and purpose: Plumbagin is the main active components of traditional Chinese medicine of plumbago zeylanica. The present studies show that plumbagin has a killing effect on tumor cells. This study aimed to investigate the function and primary mechanism of plumbagin on invasion and metastasis of human liver cancer SK-hep-1 cells. Methods: With the treatment of plumbagin in vitro, cell proliferation and adhesion of SK-hep-1 cells were detected by MTS staining, cell cycle of SK-hep-1 cells were detected by flow cytometry, the self- renewal and propagation abilities of SK-Hep-1 cells were conducted by colony formation assay, invasion in cells were performed using transwell invasion assay, and the p21 and MMP-2/9 mRNA levels were detected by real-time RT-PCR. Results: With the treatment of plumbagin, SK-Hep-1 cells proliferation was decreased with plumbagin concentration- dependency and the ICs0 value of plumbagin in SK-Hep-1 cells was 22.04 mmol/L. The colony formation ability of SK- Hep-1 cells was decreased and the percentage of cells in G0/G1 phase was increased in a dose-dependent manner, as compared to control. The cell adhesion and invasion abilities were decreased. The real-time RT-PCR showed that p21 mRNA expression was increased and the MMP-2/9 mRNA was decreased. Conclusion: Plumbagin could suppress the proliferation and invasiveness of human liver cancer SK-hep-1 cells in vitro, and these effects may be by up-regulation of p21 and down-regulation of MMP-2 and MMP-9.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2013年第9期721-727,共7页 China Oncology
关键词 增殖 肿瘤转移 白花丹醌 肝癌 SK-hep-1 Proliferation Tumor metastasis Plumbagin Hepatocarcinoma SK-hep-1
  • 相关文献

参考文献16

  • 1樊嘉,王征.肝移植治疗原发性肝癌的现状[J].肝胆外科杂志,2011,19(5):321-323. 被引量:11
  • 2林惠珍.原发性肝癌中晚期中医证候类型的临床流行病学研究[J].南京:南京中医药大学,201l:28-42.
  • 3LIN L C, YANG L L, CHOU C J. Cytotoxic naphthoquinones and plumbagic acid glucosides from Plumbago zeylanica [ J ]. Phytochemistry, 2003, 62(4): 619-622.
  • 4SANDUR S K, PANDEY M K, SUNG B, et al. Plumbagin, Vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-I: potential role in chemosensitization [J]. Mol Cancer Res, 2010, 8:107-118.
  • 5SHEN Z, DONG Z, CHENG P, et al. Effects of plumbaginon platelet aggregation and platelet-neutrophil interactions [ J ] . Planta Med, 2003, 69, 605-609.
  • 6SHARMA I, GUSAIN D, DIXIT V P. Hypolipidaemic and antiatheroselerotic effects of plumbagin in rabbits [ J ] . Indian J Physiol Pharmacol, 1991, 35: 10-14.
  • 7SANDUR S K, ICI-IIKAWA H, SETHI G, et al. Plumbagin(5- hydroxy-2-methyl-l,d-naphthoquinone) suppresses NF- kappaB activation and NF-kappa B-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents [ J ] . J Biol Chem, 2006, 281: 17023-17033.
  • 8HSU Y L, CHO C Y, KUO P L, et al. Plumbagin (5-Hydroxy- 2-methyl-l,4-naphthoquinone) induce apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-Terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo [J ] . J Phannacol Exp Ther, 2006, 318: 484-494.
  • 9SRIMVAS P, GOPINATH G, BANERJI A, et al. Plumbagin induces reactive oxygen species,which mediate apoptosis in human cervical cancer cells [ J ] . Mol Careinog, 2004, 40: 201-211.
  • 10THASNI K A, RAKESH S, ROJINI G, et al. Estrogen- dependent cell signaling and apoptosis in BRCAl-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents [ J ] . Ann Oncol, 2008, 19: 696-705.

二级参考文献44

  • 1Fan J, Yang GS, Fu ZR, et al. Liver transplantation outcome in 1, 078 hepatocellular carcinoma patients: a muliticenter experience in Shanghai, China. J Cancer Res Clin Oncol, 2009, 135(10) :1403 - 1412.
  • 2Cheng JW, Shi YH, Fan J, et al. An immune function assay predicts post - transplant recurrence in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol, 2011,137(10) :1445 -1453.
  • 3Wang Z, Zhou J, Fan J, et al. Effect of rapamycin alone and in com- bination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res, 2008, 14(16) :5124 -5130.
  • 4Streekfus C,Bigler L. The use of soluble, salivary, e-erbB-2 for the detection anti post-operative follow-up of breast cancer in women:the results of a flve-year translational reseamh study [ J ]. Adv Dent Res,2005,18(1 ) :17-24.
  • 5Delektorskaia VV, Perevoshchikov AG, Kushlinskii NE. Expression of nnr23 and c-erbB-2 proteins in cells of primary colorectal cancer and its metastases [ J ]. Arkh Patol, 2003,65 ( 5 ) : 11 - 15.
  • 6Curran S, Dundas SR, Buxton J, et al. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis eolorectal cancers [ J ]. Clin Cancer Res,2004,10( 24 ) :8229-8234.
  • 7Roeb E,Matern S. Matrix metalloproteinases and eolorectal cancer[J].Med Kliln(Munich) ,2003,98(12) :763-770.
  • 8Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in eolorectal cancer progression and metastasis[ J]. Biochim Biophys Acta ,2004,1705 (2) : 69-89.
  • 9Koyama S. Enhanced cell surface expression of matrix metalloproteinases,and their inhibitors, and tumor-induced host response in progression of haman gastric carcinoma[ J]. Dig Dis Sci,2004,49(10) :1621-1630.
  • 10Murray GI. Matrix metalloproteinases: a muhifunctional group of molecules [ J ]. J Ptahol,2001,195 ( 2 ) : 135-137.

共引文献40

同被引文献123

引证文献7

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部